Wave Life Sciences Stock Coverage Rated Buy by Truist

Truist has initiated coverage of Wave Life Sciences (WVE) with a buy rating. This indicates a positive outlook for the stock, potentially affecting investor sentiment. While no specific target price or financial metrics were provided in the report, the initiation of coverage itself suggests confidence in the company's future performance. The move may attract more analysts to follow WVE, enhancing trading volume and market interest.